Literature DB >> 12400627

Application of the 80/20 rule in safeguarding the use of high-alert medications.

Hedy Cohen1, Michelle M Mandrack.   

Abstract

Critical care units are busy, complicated settings where the margins of error are narrow and the challenges to patient safety are ever present. Applying the 80/20 rule, front-line nurses can reduce medication errors by focusing on the safe use of "high-alert" medications. There are three primary principles that practitioners can use for safeguarding against medication errors that may result from high-alert drugs. These include: reducing or eliminating the possibility of errors, making errors visible, and minimizing the consequences of errors. These principles constitute a framework of safety that guides the development of proactive error reduction strategies.

Entities:  

Mesh:

Year:  2002        PMID: 12400627     DOI: 10.1016/s0899-5885(02)00018-7

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  5 in total

1.  Medication error in anaesthesia and critical care: A cause for concern.

Authors:  Dilip Kothari; Suman Gupta; Chetan Sharma; Saroj Kothari
Journal:  Indian J Anaesth       Date:  2010-05

2.  Raising the awareness of inpatient nursing staff about medication errors.

Authors:  Asim Ahmed Elnour; Nagy Hassan Ellahham; Huria Ismail Al Qassas
Journal:  Pharm World Sci       Date:  2007-09-20

3.  Standard concentrations of high-alert drug infusions across paediatric acute care.

Authors:  Danica Irwin; Régis Vaillancourt; Dale Dalgleish; Margot Thomas; Sylvain Grenier; Elaine Wong; Megan Wright; Margaret Sears; Dermot Doherty; Isabelle Gaboury
Journal:  Paediatr Child Health       Date:  2008-05       Impact factor: 2.253

Review 4.  Root Cause Analysis of Blunders in Anesthesia.

Authors:  Ayman Aly Rayan; Sherif Essam Hemdan; Ayman Mohamed Shetaia
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

Review 5.  Clinical review: medication errors in critical care.

Authors:  Eric Moyen; Eric Camiré; Henry Thomas Stelfox
Journal:  Crit Care       Date:  2008-03-12       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.